NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later Publication Year 2020 to 2021 Remove constraint Publication Year: <span class="from" data-blrl-begin="2020">2020</span> to <span class="to" data-blrl-end="2021">2021</span>

Search Results

1304. Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment

1305. Enforcement priorities for electronic nicotine delivery systems (ENDS) and other deemed products on the market without premarket authorization

1306. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

1307. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

1308. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report